Copyright © Inderes 2011 - present. All rights reserved.
  • Senaste
  • Börs
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
  • inderesTV
  • Portfölj
  • Forum
  • Q&A
  • Om oss
    • Följda bolag
    • Teamet
Pressmeddelande

Invitation to Surgical Science’s Capital Markets Day 2025

Surgical Science Sweden

Surgical Science invites institutional investors, analysts and media representatives to the company’s Capital Markets Day on Monday, December 8, 2025 from 14:00 to 16:30 CET.

The Capital Markets Day will be conducted as a hybrid event, with the opportunity to participate on site at Inderes Event Studio, Västra Trädgårdsgatan 19 in Stockholm, or via webcast. During the day, CEO Tom Englund, together with other members of the group management, will present the company’s strategy and financial targets. Updated financial targets will be announced in the morning of December 8.

The presentations will be held in English. Registration can be made directly via the following link: https://surgical-science-sweden.events.inderes.com/cmd-2025. For on-site participation, please register no later than December 1 via the same link.

Presentation materials and a recording of the Capital Markets Day will be made available afterwards.

Gothenburg, Sweden, October 20, 2025
Surgical Science Sweden AB (publ)

For further information, please contact:


Tom Englund, CEO
Telephone: +46-70-916 16 81
E-mail: tom.englund@surgicalscience.com

Anna Ahlberg, CFO
Telephone: +46-70-855 38 35
E-mail: anna.ahlberg@surgicalscience.com

About Surgical Science Sweden AB (publ)


Surgical Science is a global leader in evidence-based medical simulation. The company’s virtual reality simulators and customized training solutions enable surgeons and healthcare professionals to practice and improve their skills outside the operating room - enhancing patient safety and clinical outcomes. Also, Surgical Science partners with medical technology and robotics companies to integrate tailor-made simulation technology into their devices, helping them accelerate innovation and gain a competitive edge. 

Surgical Science has approximately 330 employees. The company is headquartered in Gothenburg, Sweden, and has operations in Tel Aviv, Israel; Stockholm, Sweden; Seattle and Cleveland, US; and Cardiff, UK. Through sales offices in the US and China as well as a global network of distributors, Surgical Science maintains a presence in most markets. Shares in Surgical Science Sweden AB (publ) are traded on Nasdaq First North Growth Market, Stockholm, Sweden. Certified Adviser is DNB Carnegie Investment Bank AB. 

Attachments


Invitation to Surgical Science’s Capital Markets Day 2025

Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Teamet
  • Jobba hos oss
  • Inderes som en investering
  • Tjänster för börsbolag
Vår plattform
  • FAQ
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer
Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.